Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/33176
DC FieldValueLanguage
dc.contributor.authorIrena Dimitrovskaen_US
dc.contributor.authorSava Pejkovskaen_US
dc.contributor.authorSuzana Arbutinaen_US
dc.contributor.authorGabrijela Dimoskaen_US
dc.contributor.authorAleksandra Stefanovskaen_US
dc.contributor.authorNikola Siljanovskien_US
dc.contributor.authorSonja Momchilovikjen_US
dc.contributor.authorTina Trajkovskaen_US
dc.contributor.authorMarina Todorovskaen_US
dc.contributor.authorNaim Isaen_US
dc.date.accessioned2025-04-03T08:34:13Z-
dc.date.available2025-04-03T08:34:13Z-
dc.date.issued2024-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/33176-
dc.description.abstractPulmonary thromboembolism (PTE) is potentially life-threatening disorder. The pathogenesis of pulmonary thromboembolism isn’t fully understood, but it is believed to involve imbalance between pro-coagulants and anticoagulants, as well as endothelial dysfunction and acute or chronic inflammation. Pulmonary embolism (PE) occurs when there is a disruption to the blood flow in the pulmonary artery or pulmonary branches by a thrombus that originated somewhere else. Risk factors for PE are deficiency of protein S,protein C deficiency, anti-thrombin III deficiency, LA-lupus anticoagulant, factor V Leiden deficiency, antiphospholipid syndrome (APLS), previous surgical treatment, chemotherapy, immunosuppressive drugs, immobility, overweight ,oral contraceptives, pregnancy ,history of vein thrombosis ,thrombophlebitis , varicose veins. There is a relationship between higher body mass index (BMI) and VTE, and patients with severe obesity (BMI ≥ 35) have higher risk of pulmonary thromboembolism compared with those of normal BMI. Patients with pulmonary thromboembolism may present with a spectrum of symptoms, including chest pain, shortness of breath, tachycardia, hemoptysis, asymmetric pitting edema on legs, prominent superficial collateral vessels, tenderness and pain to palpation of the leg, red or purple color, warmth on the affected leg. The diagnostic work-up of suspected pulmonary embolism includes D-dimer testing, ECG, ultrasonography of heart and CT angiography. Direct oral anticoagulants are first-line treatment options for venous thromboembolism because they are associated with a lower risk of bleeding disorders than vitamin K antagonists. Use of thrombolysis should be limited to pulmonary embolism associated with haemodynamic instability. Anticoagulants should be continued for at least 3 to 6 months to prevent early recurrences and relaps of PE. Haematological malignancies, lymphoma, lung cancers and colorectal cancers are the most common cause of PEen_US
dc.publisherAssociation of Traditional Chinese Medicine and Acupuncture Tong Da Tang TCM, Skopje R.N. Macedoniaen_US
dc.relation.ispartofUNIVERSES OPEN ACCESS INTERNATIONAL JOURNAL OF ACADEMIC RESEARCHen_US
dc.titlePulmonary embolism - Pulmonary thromboembolism in patient with rectal adenocarcinomaen_US
dc.typeArticleen_US
dc.identifier.doihttps://www.doi.org/10.59710/oaijoaru242209d-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

25
checked on May 3, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.